Most Unaware of Having Prediabetes; Mid-Stage Growth Hormone Win; Fake Wegovy Woes

More than one in three adults have prediabetes, representing around 98 million Americans, but 81% of them don’t know it, the CDC said as part of a national PSA to raise awareness.

The federal government’s dietary guidelines may soon warn against ultra-processed foods. (Washington Post)

Two phase II trials found the investigative oral drug LUM-201 significantly bolstered height velocity in patients with pediatric growth hormone deficiency, developer Lumos Pharma announced.

Following a debate at the American Medical Association’s (AMA) interim meeting of its House of Delegates a few days ago, the organization voted to support health insurance coverage parity of new obesity treatments.

Smoking tobacco was linked with an increased risk for adult-onset type 1 diabetes, particularly for those with a familial risk. (Lancet Regional Health Europe)

Three people have reportedly been hospitalized in the U.S. after using fake versions of semaglutide (Ozempic, Wegovy). (CBS News)

Women who slept only 6 hours a night for 6 weeks had impaired insulin sensitivity, which was independent of adiposity. (Diabetes Care)

Novo Nordisk said it will discontinue its long-acting insulin Levemir, but will keep its other long-acting insulin, Tresiba, on the market. (Reuters)

Hyperinsulinemia from obesity and type 2 diabetes is one of the main driving factors linking the conditions with pancreatic cancer. (Cell Metabolism)

A longitudinal study showed the risk of venous thromboembolism quickly declined after ceasing hormonal contraceptive use. (Blood)

An Oklahoma woman found out she had diabetes after her Apple watch alerted her that she was in atrial fibrillation. (New York Post)

Please enable JavaScript to view the

comments powered by Disqus.